Home » Topics » Regulatory » NMPA

NMPA
RSS

CStone cleared to begin clinical trials of CS-1001 in China

July 18, 2017

China FDA accepts fruquintinib NDA for advanced colorectal cancer

June 12, 2017

Tagrisso approved in China for NSCLC

March 27, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

U.S. and China IND clearances for Ascentage's APG-1252

Dec. 28, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Oct. 21, 2016

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...